• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY VENTRICULAR CATHETER WITH BIOGLIDE, STANDARD, 23 CM; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY VENTRICULAR CATHETER WITH BIOGLIDE, STANDARD, 23 CM; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Catalog Number 91503
Medical Device Problem Code Device Operates Differently Than Expected (2913)
Health Effect - Clinical Code Therapeutic Response, Decreased (2271)
Date of Event 02/12/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported to medtronic neurosurgery that after several regulatory pressures, the shunt effect was still not obvious, and the patient's condition did not decrease.According to the report, the patient was relieved when the valve was replaced, and the doctor suspected a valve failure.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Approximately 19.5 cm of the ventricular catheter was returned.The returned catheter was patent and met the requirements for leak testing.Therefore the complaint could not be duplicated by laboratory personnel.There was proteinaceous debris observed within the interior and exterior of the catheter.The instructions for use that accompany the device caution that ¿shunt obstruction may occur in any of the components of the shunt system.The system may become occluded internally due to tissue fragments, blood clots, tumor cell aggregates, bacterial colonization, or other debris.¿ a review of the manufacturing records showed no anomalies.All catheters are 100% inspected at the time of the manufacture.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported the doctor adjusted the setting four times, from 2.0 to 1.5 to 1.0 to 0.5, with an interval of two days between adjustments.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRICULAR CATHETER WITH BIOGLIDE, STANDARD, 23 CM
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key6664092
Report Number2021898-2017-00345
Device Sequence Number13463617
Product Code JXG
UDI-Device Identifier00613994800718
UDI-Public00613994800718
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K951258
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2017
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2018
Device Catalogue Number91503
Device Lot NumberD52330
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/07/2017
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/25/2017
Supplement Date Received by Manufacturer07/10/2017
07/10/2017
09/18/2017
Initial Report FDA Received Date06/23/2017
Supplement Report FDA Received Date08/08/2017
09/07/2017
10/10/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age54 YR
Patient Weight54
-
-